Literature DB >> 7872154

Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.

B E Levin1, H L Katzen.   

Abstract

Early cognitive changes in patients with PD are often subtle and influenced by factors that interact with the disease process, including age and age of disease onset, medication, and the specific constellation of motor symptoms. These factors notwithstanding, there is ample evidence that specific cognitive changes occur early in the course of PD. Whereas language processing deficits are infrequent, subtle changes in olfaction and contrast sensitivity have been repeatedly observed. Executive function deficits are often prominent and, as an integral part of many tasks, also influence performance on a wide range of cognitive measures. This is particularly true for memory and visuospatial dysfunction, two areas that rely heavily on executive demands. Finally, depressive symptoms are also frequent in the early stages of the disease. The significance of early behavioral changes and their prognostic implications are largely unknown and need to be assessed prospectively.

Entities:  

Mesh:

Year:  1995        PMID: 7872154

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  9 in total

1.  Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease.

Authors:  G Vingerhoets; C van der Linden; E Lannoo; V Vandewalle; J Caemaert; M Wolters; D Van den Abbeele
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 2.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

3.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

4.  Are Parkinson's Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study.

Authors:  Jacob D Jones; Jared J Tanner; Michael Okun; Catherine C Price; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2017-02-06       Impact factor: 2.892

5.  Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; F Carella; S Genitrini; D Testa; F Girotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

6.  Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Joaquim Alves da Silva; Bernardo Neto
Journal:  J Neurol       Date:  2010-08-09       Impact factor: 4.849

7.  Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Authors:  Maney Mazloom; Yoland Smith
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

Review 8.  Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review.

Authors:  Ana Lígia Silva de Lima; Luc J W Evers; Tim Hahn; Lauren Bataille; Jamie L Hamilton; Max A Little; Yasuyuki Okuma; Bastiaan R Bloem; Marjan J Faber
Journal:  J Neurol       Date:  2017-03-01       Impact factor: 4.849

9.  Probing the Role of Medication, DBS Electrode Position, and Antidromic Activation on Impulsivity Using a Computational Model of Basal Ganglia.

Authors:  Alekhya Mandali; V Srinivasa Chakravarthy
Journal:  Front Hum Neurosci       Date:  2016-09-12       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.